Literature DB >> 18625684

Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.

Shyam S Mohapatra1, Sandhya Boyapalle.   

Abstract

Virtually all children experience respiratory syncytial virus (RSV) infection at least once during the first 2 years of life, but only a few develop bronchiolitis and more severe disease requiring hospitalization, usually in the first 6 months of life. Children who recover from RSV-induced bronchiolitis are at increased risk for the development of recurrent wheeze and asthma in later childhood. Recent studies suggest that there is an association between RSV-induced bronchiolitis and asthma within the first decade of life but that this association is not significant after age 13. Despite the considerable progress made in our understanding of several aspects of respiratory viral infections, further work needs to be done to clarify the molecular mechanisms of early interactions between virus and host cell and the role of host gene products in the infection process. This review provides a critical appraisal of the literature in epidemiology and experimental research which links RSV infection to asthma. Studies to date demonstrate that there is a significant association between RSV infection and childhood asthma and that preventing severe primary RSV infections can decrease the risk of childhood asthma.

Entities:  

Mesh:

Year:  2008        PMID: 18625684      PMCID: PMC2493089          DOI: 10.1128/CMR.00054-07

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  141 in total

1.  Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis.

Authors:  J D Kellner; A Ohlsson; A M Gadomski; E E Wang
Journal:  Arch Pediatr Adolesc Med       Date:  1996-11

2.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

3.  Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness.

Authors:  H Matsuse; A K Behera; M Kumar; H Rabb; R F Lockey; S S Mohapatra
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

4.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

Authors:  R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

5.  Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice.

Authors:  R S Peebles; J R Sheller; R D Collins; A K Jarzecka; D B Mitchell; R A Parker; B S Graham
Journal:  J Med Virol       Date:  2001-02       Impact factor: 2.327

6.  Persistent activation of RelA by respiratory syncytial virus involves protein kinase C, underphosphorylated IkappaBbeta, and sequestration of protein phosphatase 2A by the viral phosphoprotein.

Authors:  V Bitko; S Barik
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.

Authors:  Jung Won Park; Christian Taube; Eun Seok Yang; Anthony Joetham; Annette Balhorn; Katsuyuki Takeda; Nobuaki Miyahara; Azzeddine Dakhama; Debra D Donaldson; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2003-12       Impact factor: 10.793

Review 8.  Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.

Authors:  Robert C Welliver
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

9.  RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA.

Authors:  H Grosfeld; M G Hill; P L Collins
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells.

Authors:  Rajneesh Malhotra; Malcolm Ward; Helen Bright; Richard Priest; Martyn R Foster; Michael Hurle; Eddie Blair; Michael Bird
Journal:  Microbes Infect       Date:  2003-02       Impact factor: 2.700

View more
  43 in total

Review 1.  Therapeutic targeting of respiratory syncytial virus G-protein.

Authors:  Lawrence M Kauvar; Jennifer L Harcourt; Lia M Haynes; Ralph A Tripp
Journal:  Immunotherapy       Date:  2010-09       Impact factor: 4.196

Review 2.  Cross-roads in the lung: immune cells and tissue interactions as determinants of allergic asthma.

Authors:  Lakshmi Ramakrishna; Victor Christoff de Vries; Maria Alicia Curotto de Lafaille
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

3.  BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection.

Authors:  Bing Tian; Jun Yang; Yingxin Zhao; Teodora Ivanciuc; Hong Sun; Roberto P Garofalo; Allan R Brasier
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

Review 4.  Neutralizing epitopes of RSV and palivizumab resistance in Japan.

Authors:  Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Fukushima J Med Sci       Date:  2017-09-01

5.  Genomewide association analysis of respiratory syncytial virus infection in mice.

Authors:  James M Stark; M Michael Barmada; Abby V Winterberg; Nilanjana Majumber; William J Gibbons; Marilyn A Stark; Maureen A Sartor; Mario Medvedovic; Jay Kolls; Kiflai Bein; Beena Mailaparambil; Marcus Krueger; Andrea Heinzmann; George D Leikauf; Daniel R Prows
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

6.  Eosinophils and their interactions with respiratory virus pathogens.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Joseph B Domachowske
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

7.  Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice.

Authors:  Jessica S Siegle; Nicole Hansbro; Cristan Herbert; Helene F Rosenberg; Joseph B Domachowske; Kelly L Asquith; Paul S Foster; Rakesh K Kumar
Journal:  Respir Res       Date:  2010-02-03

8.  CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells.

Authors:  Bing Tian; Yingxin Zhao; Mridul Kalita; Chukwudi B Edeh; Slobodan Paessler; Antonella Casola; Michael N Teng; Roberto P Garofalo; Allan R Brasier
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

Review 9.  Respiratory viruses and eosinophils: exploring the connections.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Joseph B Domachowske
Journal:  Antiviral Res       Date:  2009-04-16       Impact factor: 5.970

Review 10.  The infectious march: the complex interaction between microbes and the immune system in asthma.

Authors:  Terianne Wong; Gary Hellermann; Shyam Mohapatra
Journal:  Immunol Allergy Clin North Am       Date:  2010-11       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.